FTI
69
-7
SLG
66
4
PX
52
-3
BWA
42
-2
HSY
38
-2
INTU
60
-3
TAP
51
-2
ES
55
-5
ADP
70
-3
CHRW
48
8
LB
41
-11
KMI
59
2
IFF
60
-3
AVB
65
-2
EMN
70
-2
AVY
54
-14
HUM
30
3
SBUX
41
-3
ED
53
-5
MPC
44
3
FTI
69
-7
SLG
66
4
PX
52
-3
BWA
42
-2
HSY
38
-2
INTU
60
-3
TAP
51
-2
ES
55
-5
ADP
70
-3
CHRW
48
8
LB
41
-11
KMI
59
2
IFF
60
-3
AVB
65
-2
EMN
70
-2
AVY
54
-14
HUM
30
3
SBUX
41
-3
ED
53
-5
MPC
44
3
Financhill
Back

Third Harmonic Bio 10K Form

Buy
62

THRD
Third Harmonic Bio

Last Price:
14.72
Seasonality Move:
51.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive THRD News And Ratings

See the #1 stock for the next 7 days that we like better than THRD

THRD Financial Statistics

Sales & Book Value

Annual Sales: $863.5M
Cash Flow: $-8.81M
Price / Cash Flow: 0
Annual Sales: $6.31
Price / Book: 2.16

Profitability

EPS (TTM): -0.82000
Net Income (TTM): $-32.74M
Gross Margin: $318.13M
Return on Equity: 0%
Return on Assets: 0%

Third Harmonic Bio Earnings Forecast

Key Third Harmonic Bio Financial Ratios

  • The Gross Profit Margin over the past 4 years for THRD is 36.84%.
  • The Selling, General & Administrative Expenses for THRD have been equal to 2.32% of Gross Profit Margin.
  • The Research & Development expenses have been 2.78% of Revenue.
  • The Interest Expense is -43.82% of Operating Income.
  • The Net Earning history of THRD is -3.57% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 1 years.

Third Harmonic Bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: THRD
Website: thirdharmonicbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

THRD Technical Analysis vs Fundamental Analysis

Buy
62
Third Harmonic Bio (THRD) is a Buy

Is Third Harmonic Bio a Buy or a Sell?